CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,494 shares at an average $8.41 ($46,182)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 1,802 shares at an average $8.41 ($15,147)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 2,125 shares at an average $8.40 ($17,860)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 723 shares at an average $8.40 ($6,076)
- 4 Planned sale Chief Financial Officer sold 482 shares at an average $8.51 ($4,103)
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 324 shares at an average $8.40 ($2,723)
- 4 Planned sale Director sold 102 shares at $8.55 ($872)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 12,500 shares (grant or award)
Page 5 of 33 · 660 filings